Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with oral danazol and steroid

In: Rheumatology International · 2004 · vol. 25(5) , pp. 388–390 · doi:10.1007/s00296-004-0521-6 · PMID:15565448 · W1975263904
article OA: closed CC0
AI-generated summary by claude@2026-06+body, 2026-06-13

A systemic lupus erythematosus patient with steroid-refractory pure red cell aplasia achieved remission with combined oral danazol and low-dose prednisolone therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text

This paper describes a middle-aged Chinese patient with systemic lupus erythematosus (SLE) who developed pure red cell aplasia that was refractory to steroids and resulted in transfusion dependence. The authors treated the patient with oral danazol 200 mg twice daily in combination with low-dose prednisolone, reporting no further recurrence of anemia one month after starting therapy. The primary limitation is that this is a single-patient case report with a short follow-up and no comparator arm, so generalizability and long-term efficacy cannot be established. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 2,986 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

We describe a middle-aged Chinese systemic lupus erythematosus (SLE) patient developing steroid refractory and transfusion dependent red cell aplasia. Oral danazol 200 mg twice per day was started together with low-dose prednisolone therapy. There was no further recurrence of anemia 1 month after this combined therapy. Similar content being viewed by others

References

Choi BG, Yoo WH (2002) Successful treatment of pure red cell aplasia with plasmapheresis in a patient with systemic lupus erythematosus. Yonsei Med J 43(2):274–278 Kiely PD, McGuckin CP, Collins DA, Bevan DH et al (1995) Erythrocyte aplasia and systemic lupus erythematosus. Lupus 4:407–411 Linardaki GD, Boki KA, Fartakis A, Tzioufas AG (1999) Pure red cell aplasia as presentation of systemic lupus erythematosus: Antibodies to erythropoietin. Scand J Rheumatol 28:189–191 Abkowitz JL, Kadin ME, Powell JS, Adamson JW (1986) Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br J Haematol 63:59–67 Clark DA, Dessypris EN, Krantz SB (1984) Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood 63:277 Winkler A, Jackson RW, Kay DS (1988) High dose intravenous cyclophosphamide treatment of systemic lupus erythematosus associated aplastic anemia. Arthritis Rheum 31:693 Duarte-Salazar C, Cazarin-Barrientos J, Goycochea-Robles MV, Collazo-Jaloma J et al (2000) Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A. Rheumatol 39:1155–1157 Ilan Y, Naparstek Y (1993) Pure red cell aplasia associated with systemic lupus erythematosus: remission after a single course of intravenous immunoglobulin. Acta Haematol 89:152–154 Lippman SM, Durie BGM, Garewal HS, Giordano G et al (1986) Efficacy of danazol in pure red cell aplasia. Am J Hematol 23:373–379 Roubinian JR, Papoian R, Talal N (1977) Androgenic hormones modulate autoantibody responses and improve survival in murine lupus. J Clin Invest 59:1066–1070 Roubinian JR, Talal N, Greenspan JS, Goodman JR et al (1978) Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 147:1568–1583 Michalski JP, McCombs CC, Roubinian JR, Talal N (1983) Effect of androgen therapy on survival and suppressor cell activity in aged NZB/NZW F1 hybrid mice. Clin Exp Immunol 52:229–233 Stein CM (2001) Immunoregulatory drugs. In: Ruddy S (ed) Kelley’s Textbook of Rheumatology. W.B. Saunders, Philadelphia, pp 879–898 Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Chan, A.Y., Li, E.K., Tam, L. et al. Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with oral danazol and steroid. Rheumatol Int 25, 388–390 (2005). https://doi.org/10.1007/s00296-004-0521-6 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00296-004-0521-6

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (13)

Source provenance

openalex
last seen: 2026-05-11T06:45:02.717393+00:00
unpaywall
last seen: 2026-06-18T06:36:33.011116+00:00
License: CC0 · commercial use OK